Catalyst Awards to accelerate high-risk, high-reward cancer research projects
The inaugural Catalyst Awards fund high-risk, high-reward research projects that align with Uniquely UF assets.
The inaugural Catalyst Awards fund high-risk, high-reward research projects that align with Uniquely UF assets.
UF Health Cancer Institute scientists are teaming up with experts at The Wertheim UF Scripps Institute to target cancer’s biological mysteries and seek potential drug leads for many cancer types.
The blog series highlights how an interdisciplinary research collaboration involving Dr. Jatinder Lamba's lab led to the identification of a rare genomic phenomenon underlying CD33-negative AML.
The pilot funding was awarded to researchers in all four of the institute's research programs.
The yearlong ASH program pairs experienced mentors with pediatric and adult hematology/oncology fellows.
UF Health researchers developed a digital tool that uses artificial intelligence to accelerate the diagnosis of acute leukemias.
The score could be used to identify patients more likely to have worse outcomes and optimize their treatment.
UF Health Cancer Center member Piyush Jain, Ph.D., created diagnostics and precise genome-editing tools using CRISPR.
The projects are designed to collect preliminary data required to test novel ideas, with the goal of creating a foundation for larger studies.
The UF Health Cancer Center has expanded its research programs to strengthen the impact of cancer research and facilitate clinical translation of discoveries.